Format

Send to

Choose Destination
Clin Biochem. 2014 Mar;47(4-5):245-51. doi: 10.1016/j.clinbiochem.2013.11.023. Epub 2013 Dec 15.

Biobanks containing clinical specimens: defining characteristics, policies, and practices.

Author information

1
H.W. Odum Institute for Research in Social Science, University of North Carolina-Chapel Hill, C.B. 3355, Chapel Hill, NC 27599, USA. Electronic address: teresa_edwards@unc.edu.
2
Department of Social Medicine, University of North Carolina-Chapel Hill, C.B. 7240, Chapel Hill, NC 27599, USA. Electronic address: cadigan@ad.unc.edu.
3
Department of Genetics, University of North Carolina-Chapel Hill, C.B. 7264, Chapel Hill, NC 27599, USA. Electronic address: jpevans@med.unc.edu.
4
Department of Social Medicine, University of North Carolina-Chapel Hill, C.B. 7240, Chapel Hill, NC 27599, USA. Electronic address: gail_henderson@med.unc.edu.

Abstract

OBJECTIVES:

Biobanks - collections of human biological specimens stored for future research use - are crucial for biomedical advancement. One of the most common ways that biobanks acquire specimens is to obtain residual or "leftover" samples originally collected for clinical care from hospitals, clinical laboratories and pathology departments. Little is known about the characteristics of biobanks that store specimens from clinical sources, or their policies and practices.

DESIGN AND METHODS:

In this paper, we present data from the subset of 261 biobanks in our 2012 national survey that stores specimens from clinical sources, focusing on a number of ethical issues that have been raised in the literature.

RESULTS:

Most biobanks are part of larger organizations, mainly academic medical centers, and most report standardized systems for managing acquisition, storage, and release to researchers. Yet, there is considerable diversity in policies and practices regarding informed consent, return of research results, ownership of specimens and technology developed, utilization, and disposition of remaining specimens after researchers have acquired, them. We document tremendous heterogeneity in the composition of these collections, the number and type of specimens stored, and number of requests for specimens per year.

CONCLUSION:

Responding to this variation presents significant challenges for those who manage the collections, demanding careful consideration and planning to maintain high quality practices in acquisition, storage, and release of specimens all the while striving to protect the rights of subjects.

KEYWORDS:

Ethics of biobanking

PMID:
24345347
PMCID:
PMC3959281
DOI:
10.1016/j.clinbiochem.2013.11.023
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center